Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Go back to Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
(NASDAQ: AMLX) Delayed: 32.39 -0.02 (0.06%)
Previous Close $32.41    52 Week High
Open $32.55    52 Week Low
Day High $33.16    P/E N/A 
Day Low $31.90    EPS
Volume 1,005,646